Vertex Pharma stock slips 1.55 percent pre-market before the open
Published on 09/21/2026 at 05:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharma stock closed at USD 508.34 on Nasdaq on September 18, 2026, down 1.55 percent. The session finished below the prior close of USD 516.34 and alongside volume of 2,434,832 shares.
September 18, 2026 in numbers
Vertex Pharmaceuticals Incorporated (ISIN US92532F1003, Nasdaq: VRTX) traded between USD 505.01 and USD 518.10, so the close sat near the lower end of the day range. The shares ended the session 9.8 percent below the 52-week high of USD 560.25 and 35.8 percent above the 52-week low of USD 374.17, according to MarketBeat.
Reuters showed the stock at USD 508.34, with the S&P 500 closing at 7,650.50 and the Dow Jones Industrial Average at 51,682.64 on September 21, 2026, giving the stock a weak backdrop versus the broader market. The U.S. calendar is also set for a normal session today.
Today, September 21, 2026
MarketBeat lists the next earnings date as November 2, 2026, and the Bank of America Global Healthcare Conference on September 23, 2026. That leaves the stock without a company-specific event before the open today, while sector trading and broader U.S. market moves remain the main outside factors.
